Skip to main content

5G Substrate Materials Market Demand, Trends and Forecast 2021-2031

5G is the new communication backbone that will enable revolutionary applications in industrial, medical, automotive, and defense markets. 5G comes with enormous benefits such as improvement in speed (ten times that of 4G), latency (at least ten times lower than 4G), and density (supporting approximately one million IoT devices per square kilometer). The 5G technology will enhance the overall security, reliability, quality of service, and efficiency of the devices.

Read Report Overview: https://bisresearch.com/industry-report/global-5g-substrate-materials-market.html

5G technology has acted as a boon for various applications such as 5G smartphones, IoT, and autonomous vehicles. The key hardware requirement of these 5G end-user applications is active antenna systems. These active antenna systems enable the concept of remote radio head by integrating the antenna and meet 5G challenges of enhanced capacities using space diversity and localized beams via massive multiple-input multiple-output (MIMO) technology. These MIMOs are used in 5G base stations and smartphones. Various companies are working on conducting research and developing 5G-enabled substrate materials for antenna circuit boards. Some of the key market players are DuPont de Nemours, Inc., Hitachi Chemical Company, Ltd., Rogers Corporation, and Toray Industries, Inc. The primary task is to minimize materials costs, complexity, and integrating circuits. Several of these companies are working on enhancing their substrate materials to serve a larger platter of end-use industries.

Countries are working on the deployment of 5G, curating various investment strategies, and collaborations in the market. More than 20+ countries across the world have access to 5G networks now. China, South Korea, and the U.S. are the top players deploying 5G at a breakneck pace in their cities. The key telecom players of various regions have been publicly announcing their 5G contracts for the deployment of 5G in their countries. For instance, North America has AT&T, Verizon, Sprint, and T-Mobile. Europe has a very fragmented telecom sector with a bunch of players such as Orange France, Swisscom, Vodafone Germany, and DiGi, among others. MEA has Zain, Etisalat, and MTN. APAC countries also have significant telecom players such as SK Telecom, SoftBank, LG U+, and Optus.


These companies are collaborating with equipment manufacturers and suppliers such as Ericsson, Huawei, and Nokia to deploy 5G base station antennas in the base station towers. The growth in deployment of 5G base stations will automatically drive the demand for 5G substrate materials such as PTFE, PEEK, LCPs, and ceramics. These materials accelerate the performance of a 5G circuit board, enhancing the overall efficiency of the device. The shift toward 5G technology also affects the business development and commercialization activities of materials. Firms are aiming at entering the 5G material development segment, leveraging upon the growing demand in the market. Various companies with expertise in advanced chemicals and materials business segments have shown interest in venturing into the 5G substrate materials market. This is due to the high demand and growth prospects of the 5G business segment.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...